EAM
CORZ

Exos Asset Management’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Exos Asset Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$16K Buy
10,713
+2,257
+27% +$10.4K 0.01% 256
2022
Q1 		$70K Buy
8,456
+1,651
+24% +$14.6K 0.03% 229
2021
Q4 		$75K Sell
6,805
-4,728
-41% -$55.8K 0.04% 272
2021
Q3 		$117K Buy
+11,533
New +$116K 0.06% 275

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Exos Asset Management's CORZ Position: Q2 2022 in Review

Exos Asset Management increased its Core Scientific, Inc. Common Stock (CORZ) stake by 27% in Q2 2022, buying an estimated $10.4K and bringing the position to 10,713 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #256.

Exos Asset Management first reported a position in CORZ in Q3 2021 and has held it in 4 quarters since. The position peaked at $117K in Q3 2021. 141 funds tracked by Wall St. Rank hold CORZ as of Q2 2022.

  • Exos Asset Management held 10,713 shares of Core Scientific, Inc. Common Stock worth $16K as of Q2 2022.
  • Exos Asset Management bought 2,257 Core Scientific, Inc. Common Stock shares in Q2 2022, an estimated $10.4K.
  • Core Scientific, Inc. Common Stock made up 0.01% of Exos Asset Management's portfolio in Q2 2022, its #256 holding.
  • Exos Asset Management first reported a position in Core Scientific, Inc. Common Stock in Q3 2021 and has held it in 4 quarters since.
  • Exos Asset Management's Core Scientific, Inc. Common Stock position peaked at $117K in Q3 2021.
  • 141 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.